Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements
Stock Information for Bright Minds Biosciences Inc Ordinary Shares
Loading
Please wait while we load your information from QuoteMedia.